Panacea Biotec Ltd
Panacea Biotec | 531349
Share Price Chart - Panacea Biotec Ltd
Stock Performance
Ratios
About Company
- India's leading research-based health management company with established research, manufacturing and marketing capabilities are collectively known as Panacea Biotec Limited (PBL), which was incorporated on February 2, 1984 under the name of Panacea Drug (P) Limited
- The name of the Company was changed to the present 'Panacea Biotec Limited' in 1993
- A second largest vaccine producer in India has the product portfolio of highly innovative prescription products in important therapeutic areas such as pain management, diabetes management, renal-disease management, anti-osteoporosis, anti-tubercular, gastro-intestinal care products and vaccines
- The plant for vaccines production (Radicura Pharma) and pharmaceutical formulations plant (Panacea Drug P Ltd) at New Delhi were established during the year 1988 and 1989 respectively
- In 1993, merger of Panacea Drugs (P) Ltd and Radicura Pharma gave the name Panacea Biotec Ltd
- The Company made its Initial Public Offering (IPO) in the year of 1995 and also in the same year, PBL had formed state -of the- art Drug Delivery R&D centre at Lalru
- In the year 1997, the company obtained its first product patent in several countries
- PBL's Research & Development made a tie up with European MNC in the year 2001 and in 2002, an in-licensing agreement was made with Biotechnology Consortium of India for development & commercialization of Anthrax Vaccine
- Also in the identical year of 2002, the company had commissioned Recombinant Vaccine production plant
- During the year 2004, PBL made an in-licensing agreement with National Institute of Immunology, New Delhi, for Japanese Encephalitis Candidate Vaccine, marketing joint venture with Chiron (now Novartis) Vaccines, UK and also made collaboration with Cambridge Bio-stability, UK, for Thermo Stable Vaccines
Ethics: Panacea Biotec Ltd is flagged for
Below average
---
Research Calls
Technical Indicators
Pivot Points
Volume Analysis
Growth Rate
All figures in ₹ Crores
No Information Available
No shareholding data available at this time.
No Data Available
No Block Deals data available for this company.
News
No Information Available
Peers
#IndiaInvests
Trusted by 2.5 lac + Indians for their wealth-building needs
Invest in stocks with ease
Open your account in less than 10 mins*
By proceeding, you agree to all T&C *
Top Gainers
Frequently Asked Questions
What is Share Price of Panacea Biotec Ltd?
The current share price of Panacea Biotec Ltd (Panacea Biotec) is ₹546.60. This price reflects the latest market valuation and is updated in real-time during trading hours.
What is the P/E Ratio of Panacea Biotec Ltd?
The Price-to-Earnings (P/E) ratio of Panacea Biotec Ltd is 546.60. This indicates how much investors are willing to pay per rupee of earnings, helping assess if the stock is overvalued or undervalued.
What is the 52-week high and low of Panacea Biotec Ltd?
Panacea Biotec Ltd has a 52-week high of ₹647.00 and a 52-week low of ₹292.40. This range shows the stock's price volatility over the past year.
What is the Dividend Yield of Panacea Biotec Ltd?
Panacea Biotec Ltd offers a dividend yield of 0.00%. This represents the annual dividend payment as a percentage of the current stock price, indicating the income return for investors.
What is the EPS of Panacea Biotec Ltd?
The Earnings Per Share (EPS) of Panacea Biotec Ltd is ₹-3.99. EPS indicates the company's profitability on a per-share basis and is a key metric for evaluating financial performance.
What is the ROE of Panacea Biotec Ltd?
Panacea Biotec Ltd has a Return on Equity (ROE) of 0.00%. ROE measures how effectively the company uses shareholders' equity to generate profits, with higher values generally indicating better performance.
Disclaimer:
Please note that the above list and information is for research purposes only and are not recommendations. Do your own due diligence or consult an investment advisor before investing. The above data is dynamic in nature and subject to real-time changes and is derived from CMOTS.
